GEN DIGITAL INC

Gen Digital’s new AI Data Checker lets users see which agentic AI services link to their accounts and how their data may be used, boosting transparency and privacy.

Gen Digital (NASDAQ: GEN) faces sector sell‑off yet offers strong AI, cybersecurity, and compliance tools poised to grow—an insider look at risks & opportunities.

Gen Digital’s share slide shows how tightening yields and ad‑spend cuts hit a high‑debt tech firm. Discover the company’s revenue mix, regulatory risks and potential for diversification.

Gen Digital’s directors swap cash for RSUs—multi‑year equity awards that align board incentives with long‑term shareholder value and ESG goals.

Gen Digital’s latest filings reveal a major executive share sale, a definitive proxy supplement backing director re‑elections, and a proactive move to reinforce board independence—all crucial details investors should review before the 2026 Annual Me…

Gen Digital’s insider stake jump and premium CPG rollout show how board‑level confidence, tech‑driven supply chains, and consumer‑centric retail expansion drive growth and governance risks.

Gen Digital beats Q1 earnings, raises 2027 guidance, and unveils a quarterly dividend as cybersecurity & wellness demand surges under new data‑protection rules.

Generation Uranium’s shift to the CSE cuts fees, boosts funds for its Yath uranium project, and refocuses capital strategy while keeping broad investor access.

General Capital’s 2026 shareholder nomination rules: strict deadlines, written consent, and secure digital channels—boosting board transparency while weighing investor access and data privacy.

GEN Digital’s Phase II SHEPHERD trial of mitochondrial‑targeting therapy SUL‑238 for Parkinson’s disease shows how biomarker‑driven, early‑intervention research could shift the disease‑modifying paradigm.